Avanos Medical, Inc. Share Price

Equities

AVNS

US05350V1061

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:30:02 27/04/2024 am IST 5-day change 1st Jan Change
18.1 USD +1.40% Intraday chart for Avanos Medical, Inc. -3.26% -19.30%
Sales 2024 * 691M 57.62B Sales 2025 * 729M 60.75B Capitalization 781M 65.14B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.13 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.07 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 3,771
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.40%
1 week-3.26%
Current month-9.09%
1 month-7.61%
3 months-5.53%
6 months+2.61%
Current year-19.30%
More quotes
1 week
17.79
Extreme 17.79
19.16
1 month
17.79
Extreme 17.79
20.13
Current year
17.39
Extreme 17.39
23.09
1 year
17.24
Extreme 17.235
30.28
3 years
17.24
Extreme 17.235
45.82
5 years
17.24
Extreme 17.235
53.61
10 years
17.24
Extreme 17.235
72.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 26/17/26
Director of Finance/CFO 51 01/20/01
Compliance Officer - 15/20/15
Members of the board TitleAgeSince
Chairman 66 31/14/31
Director/Board Member 66 31/14/31
Director/Board Member 71 31/14/31
More insiders
Date Price Change Volume
26/24/26 18.1 +1.40% 133,303
25/24/25 17.85 -4.60% 230,915
24/24/24 18.71 -0.27% 169,979
23/24/23 18.76 -1.00% 125,765
22/24/22 18.95 +1.28% 185,786

Delayed Quote Nyse, April 27, 2024 at 01:30 am IST

More quotes
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Calendar
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
18.1 USD
Average target price
23.5 USD
Spread / Average Target
+29.83%
Consensus